Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
HER2 Positive Gastric Cancer
×
pembrolizumab
×
1 year
×
Clear all
Filters
3
NCT04727151
2025-06-08
TACTIC-2
Triumvira Immunologics, Inc.
Phase 1/2
Terminated
28 enrolled
23 charts